Ginger, a San Francisco, CA-based on-demand mental healthcare company, raised $50m in Series D funding.
The round, which brought total funding to over $120m, was led by Advance Venture Partners and Bessemer Venture Partners with participation from Cigna Ventures and existing investors such as Jeff Weiner, Executive Chairman of LinkedIn, and Kaiser Permanente Ventures.
With this round, Ginger has added David ibnAle and Steve Kraus to its Board of Directors.
David ibnAle is a Founding Partner of Advance Venture Partners (AVP), an investment firm built in partnership with Advance, a family-owned holding company with a diversified portfolio of exceptional media and technology companies. He has over 20 years of experience investing in enterprise and consumer technology companies and currently sits on the boards of high-growth software companies such as Affinity, PebblePost and Morning Consult.
Steve Kraus is a Partner at Bessemer Venture Partners and leads their healthcare investment practice. He currently sits on the boards of leading digital health companies such as Bright Health, Hinge Health, Artemis Health, Groups and Welltok.
Led by Russell Glass, CEO, Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy and psychiatry from a smartphone. Today, over 200 companies ranging from startups to Fortune 100s, including Delta Air Lines, Sanofi, Chegg, Domino’s, SurveyMonkey, and Sephora, partner with Ginger to provide employees with mental healthcare. Ginger members can also access virtual therapy and psychiatry sessions as an in-network benefit through the company’s relationships with regional and national health plans, including Optum Behavioral Health, Anthem California, and Aetna Resources for Living.